These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12830409)

  • 61. A review of the Manitoba home i.v. antibiotic program.
    Cote D; Oruck J; Thickson N
    Can J Hosp Pharm; 1989 Aug; 42(4):137-41. PubMed ID: 10294299
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Redundant combinations of antianaerobic antimicrobials: impact of pharmacist-based prospective audit and feedback and prescription characteristics.
    Kim M; Kim HS; Song YJ; Lee E; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Park SW; Kim NJ; Oh MD; Kim HB
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):75-83. PubMed ID: 31482420
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessment of cost-effective antibiotic therapy in the management of infections in cancer patients.
    Cimino MA; Rotstein CM; Moser JE
    Ann Pharmacother; 1994 Jan; 28(1):105-11. PubMed ID: 8123946
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Economic impact of redundant antimicrobial therapy in US hospitals.
    Schultz L; Lowe TJ; Srinivasan A; Neilson D; Pugliese G
    Infect Control Hosp Epidemiol; 2014 Oct; 35(10):1229-35. PubMed ID: 25203175
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Use physician education to cut prescription drug costs.
    Capitation Manag Rep; 1999 Jul; 6(7):100-3, 97. PubMed ID: 10539514
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vancomycin Use: Room for Improvement Among Hospitalized Children.
    Gillon J; Xu M; Slaughter J; Di Pentima MC
    J Pharm Pract; 2017 Jun; 30(3):296-299. PubMed ID: 27044642
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacist-monitored, computerized drug usage review.
    Jacinto MS; Kleinmann K; Margolin J
    Am J Hosp Pharm; 1974 May; 31(5):508-12. PubMed ID: 4829393
    [No Abstract]   [Full Text] [Related]  

  • 68. Improving the quality of antimicrobial drug use can result in cost containment.
    Gyssens IC; Kullberg BJ
    Pharm World Sci; 1995 Sep; 17(5):163-7. PubMed ID: 8574212
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team.
    Gums JG; Yancey RW; Hamilton CA; Kubilis PS
    Pharmacotherapy; 1999 Dec; 19(12):1369-77. PubMed ID: 10600085
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Application of decision analysis in antibiotic formulary choices.
    Szymusiak-Mutnick B; Mutnick AH
    J Pharm Technol; 1994; 10(1):23-6. PubMed ID: 10133008
    [TBL] [Abstract][Full Text] [Related]  

  • 71. How we developed a comprehensive data base for antibiotic use.
    Vandel K
    Pharm Times; 1987 Apr; 53(4):98-100. PubMed ID: 10281924
    [No Abstract]   [Full Text] [Related]  

  • 72. Drug costs. Antibiotic pharmacist saves 10 pounds sterling per patient per day.
    Jones D; Cheesbrough J
    Health Serv J; 2005 Mar; 115(5948):30. PubMed ID: 15825656
    [No Abstract]   [Full Text] [Related]  

  • 73. Pharmacoeconomic decision making: a new type of medication error.
    Dubois RW
    West J Med; 1999 Sep; 171(3):162-3. PubMed ID: 10610601
    [No Abstract]   [Full Text] [Related]  

  • 74. Audit of parenteral antimicrobial agents and infusion fluids.
    Redding PJ; Taylor A; Smith AM
    Health Bull (Edinb); 1995 Mar; 53(2):110-4. PubMed ID: 7737872
    [No Abstract]   [Full Text] [Related]  

  • 75. Optimizing antimicrobial therapy through a pharmacist-managed culture review process in the ED.
    Van Devender EA
    Am J Emerg Med; 2014 Sep; 32(9):1138. PubMed ID: 24985944
    [No Abstract]   [Full Text] [Related]  

  • 76. Antibiotic formulary selection.
    Crowe HM; Quintiliani R
    Med Clin North Am; 1995 May; 79(3):463-76. PubMed ID: 7752722
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibiotic surveillance.
    Straitiff PA
    Med Rec News; 1977 Jun; 48(3):58, 60-2. PubMed ID: 10305621
    [No Abstract]   [Full Text] [Related]  

  • 78. Expanding the role of the infection control professional in the cost-effective use of antibiotics.
    Minooee A; Rickman LS
    Am J Infect Control; 2000 Feb; 28(1):57-65. PubMed ID: 10679139
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Managing an antibiotic surveillance program: written criteria and data collection.
    Keys PW
    Curr Concepts Hosp Pharm Manage; 1981; 3(3):14-8. PubMed ID: 10253723
    [No Abstract]   [Full Text] [Related]  

  • 80. A randomized trial of a computer-based intervention to reduce utilization of redundant laboratory tests.
    Bates DW; Kuperman GJ; Rittenberg E; Teich JM; Fiskio J; Ma'luf N; Onderdonk A; Wybenga D; Winkelman J; Brennan TA; Komaroff AL; Tanasijevic M
    Am J Med; 1999 Feb; 106(2):144-50. PubMed ID: 10230742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.